Why Abzena?
Our focused approach.
Abzena’s dedicated and recently upgraded bioconjugation facility in Bristol, PA, can handle a variety of batch sizes to support preclinical and clinical manufacture of bioconjugates and antibody drug conjugates (ADCs).
Our experienced teams are committed to ensuring your program meets its preclinical, clinical and commercial goals. We have a network of aligned facilities that meet your biologics manufacturing needs across the lifecycle of your molecule.
Our manufacturing services are complemented by over 20 years of expertise in process development and optimization, as well as analytics and bioassays.
Abzena’s Quality organization provides safe and compliant products to your patients.
Our Quality organization has a comprehensive program of quality services to ensure compliance with regulatory requirements.
In addition to our expertise, we have the technologies and analytical capabilities to handle any of your modalities; from the simple to the most complex.
Our modern, recently updated bioconjugate and ADC facility located in Bristol, PA, deploys the latest in technology and processing.
Our facility in Bristol have a long history of specializing in bioconjugation, quality linker payloads, highly potent materials and complex chemistry.
Our Bristol, PA facility provides preclinical, clinical through commercial manufacturing support for bioconjugate drug programs.
The asset you’re developing right now can make a real difference for human health. Let us apply our wealth of experience to accelerate and maximize its potential.